Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose Escalation of Allogeneic Adipose Derived Stroma/Stem Cells for the Treatment of Crohn's Fistula:a Phase I/II Clinical Study

NCT06636032 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT06636032
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06636032 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose Escalation of Allogeneic Adipose Derived Stroma/Stem Cells for the Treatment of Crohn's Fistula:a Phase I/II Clinical Study
Lead sponsor
University Hospital, Toulouse
Phase
Phase 1/2
Overall status
Recruiting
Start date
March 12, 2025
Completion date
September 30, 2027
Enrollment
9 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease